Cognitive Behavioral Therapy for Chronic Pelvic Pain Syndrome
(EPPIC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new, short version of cognitive behavioral therapy (CBT) to help individuals with chronic pelvic pain syndrome improve their well-being. CBT teaches ways to manage pain and other symptoms affecting daily life. The study compares this therapy to educational support to determine which is more effective. Individuals who have experienced moderate pelvic pain for at least six months, impacting their daily activities, might be suitable candidates for this trial. As an unphased trial, it offers a unique opportunity to explore innovative therapy options that could significantly enhance quality of life.
Do I need to stop my current medications to join the trial?
You don't have to stop your current medications, but you should not start any new ones until after the initial 2-week pre-treatment baseline period, unless it's medically necessary.
What prior data suggests that this cognitive behavioral therapy is safe for treating chronic pelvic pain syndrome?
Research has shown that Cognitive Behavioral Therapy (CBT) is generally safe for treating long-term pain, including chronic pelvic pain. CBT helps individuals manage pain using practical techniques. Studies have found that CBT can effectively address chronic pain without causing major side effects.
One study demonstrated that combining CBT with regular care reduced pain and improved function over time. Another study confirmed that CBT is effective for chronic pain and is generally safe, with most individuals tolerating it well and few reports of serious problems.
Overall, Minimal Contact-Cognitive Behavior Therapy (MC-CBT) appears to be a safe choice for those with chronic pelvic pain. It focuses on teaching skills to manage pain and improve quality of life.12345Why are researchers excited about this trial?
Researchers are excited about Minimal Contact-Cognitive Behavior Therapy for chronic pelvic pain syndrome because it offers a fresh approach by focusing on teaching patients practical self-management tools. Unlike typical treatments that often rely on medication to relieve pain and urinary symptoms, this therapy targets the biobehavioral factors that can worsen these symptoms. This method empowers patients to actively manage their condition, potentially leading to long-term relief without the side effects associated with standard pharmaceutical options.
What evidence suggests that this trial's treatments could be effective for chronic pelvic pain syndrome?
Research shows that Cognitive Behavioral Therapy (CBT) effectively treats chronic pelvic pain, including urologic chronic pain syndrome (UCPPS). In this trial, participants may receive Minimal Contact-Cognitive Behavior Therapy, which teaches practical tools and strategies for self-care to manage pain. Strong evidence supports CBT, with over 20 reviews and analyses confirming its benefits for chronic pain. Although the exact mechanisms remain unclear, patients often experience reduced pain and fewer related symptoms. Overall, CBT focuses on the interaction between the body and mind in worsening pelvic pain, making it a promising option for many.12678
Who Is on the Research Team?
Jeffrey Lackner, PsyD
Principal Investigator
University at Buffalo (SUNY)
Are You a Good Fit for This Trial?
The EPPIC study is for adults aged 18-70 with a doctor-confirmed diagnosis of chronic pelvic pain syndromes like interstitial cystitis or chronic prostatitis. Participants must have had pelvic pain for at least six months, be willing to attend therapy sessions, and not start new medications during the initial study period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 4-session cognitive behavioral therapy or education/support control over a 10-week acute phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Minimal Contact-Cognitive Behavior Therapy
- Patient Education/Support
Minimal Contact-Cognitive Behavior Therapy is already approved in United States for the following indications:
- Chronic Pelvic Pain Syndrome
- Urologic Chronic Pelvic Pain Syndrome (UCPPS)
- Interstitial Cystitis/Bladder Pain Syndrome
- Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
University of Michigan
Collaborator
University of California, Los Angeles
Collaborator